Skip to content
AwardedPRTGoodsFramework agreement€430,008

ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA+TENOFOVIR ALAFENAMIDA 2º SEMESTR

Published
Published 2 December 2025

Overview

ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA+TENOFOVIR ALAFENAMIDA 2º SEMESTR

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€430,008
Procedure
Selective
Contract type
Framework agreement
Published
2 December 2025
Classification (CPV)
Pharmaceutical productsVarious medicinal products

Award outcome

Award date
19 May 2025
Contract period
— → 18 June 2025
Winner
  • GILEAD SCIENCES, LDA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    1 December 2025

Contracting authority

  • Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)

    Procuring entity

    Funchal, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA+TENOFOVIR ALAFENAMIDA 2º SEMESTR — won by GILEAD SCIENCES, LDA — Skim